Cargando…
A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers
BACKGROUND: Transplantation of mesenchymal stem cells has created enormous opportunities as a potential treatment for various diseases including neurodegenerative diseases. Given current techniques, such as Hoechst labeling, have safety and leakage issues, our study focused, as a proof-of-concept, o...
Autores principales: | Munro, Nikolas, Srinageshwar, Bhairavi, Shalabi, Firas, Florendo, Maria, Otero, Paulina, Thompson, Cassandra, Kippe, Jordyn, Malkowski, Clayton, Climie, Sydney, Stewart, Andrew N., Kim, Rachel, Zhou, Joseph, Swanson, Douglas, Dunbar, Gary L., Sharma, Ajit, Rossignol, Julien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393977/ https://www.ncbi.nlm.nih.gov/pubmed/30819246 http://dx.doi.org/10.1186/s13287-019-1171-7 |
Ejemplares similares
-
Use of Polyamidoamine Dendrimers in Brain Diseases
por: Florendo, Maria, et al.
Publicado: (2018) -
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
por: Fana, Michael, et al.
Publicado: (2020) -
PAMAM Dendrimers Cross the Blood–Brain Barrier When Administered through the Carotid Artery in C57BL/6J Mice
por: Srinageshwar, Bhairavi, et al.
Publicado: (2017) -
A Mixed-Surface Polyamidoamine Dendrimer for In Vitro and In Vivo Delivery of Large Plasmids
por: Srinageshwar, Bhairavi, et al.
Publicado: (2020) -
Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines
por: Gallien, John, et al.
Publicado: (2021)